Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Clinicoeconomics and Outcomes Research : CEOR
|
May 13, 2017
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
Jack Burks, Thomas S Marshall, Xiaolan Ye
The Journal of Prosthetic Dentistry
|
March 6, 2012
Supplementing retention through crown/preparation modification: an in vitro study
Hal O'Kray, Thomas S Marshall, Thomas M Braun
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2008
Impact of patient selection criteria and treatment history on comparisons of alternative therapies: a case study of atypical antipsychotics
Thomas S Marshall, Jeffery S McCombs, Dana Stafkey-Mailey
Clinical Drug Investigation
|
November 12, 2013
Cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin D for management of secondary hyperparathyroidism in haemodialysis patients in the USA
Amit Sharma, Thomas S Marshall, Samina S Khan, et al.
Clinical Drug Investigation
|
March 1, 2015
Health economic evaluation of paricalcitol(®) versus cinacalcet + calcitriol (oral) in Italy. [corrected]
Mark Nuijten, Daniela P Roggeri, Alessandro Roggeri, et al.
Journal of Medical Economics
|
July 10, 2013
Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients
Amit Sharma, Markus Ketteler, Thomas S Marshall, et al.
Journal of Drugs in Dermatology : JDD
|
June 3, 2010
Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis
Charu Taneja, Richard J Antaya, Ariel Berger, et al.
International Urology and Nephrology
|
August 15, 2013
Antimuscarinic use among individuals with urinary incontinence who reside in long-term care facilities
Ning Wu, Thomas S Marshall, Luke Boulanger, et al.
Journal of Medical Economics
|
September 13, 2017
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease
Julia Lowin, Kavita Sail, Rakhi Baj, et al.
Current Medical Research and Opinion
|
March 3, 2009
Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage
Miriam G Cisternas, Aimee J Foreman, Thomas S Marshall, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Clinicoeconomics and Outcomes Research : CEOR
|
May 13, 2017
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
Jack Burks, Thomas S Marshall, Xiaolan Ye
The Journal of Prosthetic Dentistry
|
March 6, 2012
Supplementing retention through crown/preparation modification: an in vitro study
Hal O'Kray, Thomas S Marshall, Thomas M Braun
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2008
Impact of patient selection criteria and treatment history on comparisons of alternative therapies: a case study of atypical antipsychotics
Thomas S Marshall, Jeffery S McCombs, Dana Stafkey-Mailey
Clinical Drug Investigation
|
November 12, 2013
Cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin D for management of secondary hyperparathyroidism in haemodialysis patients in the USA
Amit Sharma, Thomas S Marshall, Samina S Khan, et al.
Clinical Drug Investigation
|
March 1, 2015
Health economic evaluation of paricalcitol(®) versus cinacalcet + calcitriol (oral) in Italy. [corrected]
Mark Nuijten, Daniela P Roggeri, Alessandro Roggeri, et al.
Journal of Medical Economics
|
July 10, 2013
Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients
Amit Sharma, Markus Ketteler, Thomas S Marshall, et al.
Journal of Drugs in Dermatology : JDD
|
June 3, 2010
Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis
Charu Taneja, Richard J Antaya, Ariel Berger, et al.
International Urology and Nephrology
|
August 15, 2013
Antimuscarinic use among individuals with urinary incontinence who reside in long-term care facilities
Ning Wu, Thomas S Marshall, Luke Boulanger, et al.
Journal of Medical Economics
|
September 13, 2017
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease
Julia Lowin, Kavita Sail, Rakhi Baj, et al.
Current Medical Research and Opinion
|
March 3, 2009
Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage
Miriam G Cisternas, Aimee J Foreman, Thomas S Marshall, et al.
Page
of 2